1984 Volume 32 Issue Supplement2 Pages 191-195
To evaluate the clinical efficacy of TA-058, the treatment was made with the drug in 17 patients including 5 with bacterial pneumonia, 2 with primary atypical pneumonia, 2 with mycoplasma pneumonia, 3 with acute bronchitis, 1 with chronic brochitis, 1 with acute cystitis, 1 with acute pyelonephritis, and 1 with chronic pyelonephritis. Response was excellent in 2 patients, good in 13 and poor in 2.
Side effect observed was warm feeling during the infusion in 1 patient. Laboratory abnormalities were observed as slight eosinophilia in 1 and slight elevations of GOT and GPT in 1 patient.